Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma. [electronic resource]
Producer: 20191011ISSN:- 1946-6242
- Adenocarcinoma of Lung -- diagnosis
- Aged
- Aged, 80 and over
- Animals
- Biological Transport -- drug effects
- Cell Differentiation
- Cell Proliferation -- drug effects
- Female
- Glucose -- metabolism
- Glucose Transporter Type 1 -- metabolism
- Humans
- Male
- Mice, SCID
- Mice, Transgenic
- Middle Aged
- Molecular Targeted Therapy
- Neoplasm Staging
- Positron-Emission Tomography
- Precancerous Conditions -- metabolism
- Sodium-Glucose Transporter 2 -- metabolism
- Sodium-Glucose Transporter 2 Inhibitors -- pharmacology
- Survival Analysis
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.